Literature DB >> 21224686

[A case report of unresectable hepatocellular carcinoma (HCC) with portal vein tumor thrombus responding to DSM-TACE (degradable starch microspheres-transcatheter arterial chemoembolization)].

Masato Kirihara1, Michio Nagashima, Kyoko Higuchi, Hideaki Tahira, Masayuki Tajima.   

Abstract

A 56-year-old man was revealed to be HCC with portal vein tumor thrombus. Curative operation was impossible because we recognized many daughter lesions in the liver. Tumor marker was very high. DSM-TACE was conducted as the first line therapy. There was no remarkable side effect. After two-course, the size of HCC was decreased in CT and tumor marker was normalized. Generally speaking, a prognosis of HCC with portal vein tumor thrombus is poor. Hence, DSM-TACE is one of the effective therapies for HCC with portal vein tumor thrombus.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21224686

Source DB:  PubMed          Journal:  Gan To Kagaku Ryoho        ISSN: 0385-0684


  2 in total

1.  Assessment of the feasibility of TACE combined with intratumoral injection of cisplatin in hepatocellular carcinoma.

Authors:  Song Zhaomin; Liu Zifeng; Yin Chenghui; Yang Jiali; Peng Xun; Zhao Peili; Lang Xiaolin
Journal:  Open Med (Wars)       Date:  2015-12-17

Review 2.  Role of Pretransplant Treatments for Patients with Hepatocellular Carcinoma Waiting for Liver Transplantation.

Authors:  Kohei Ogawa; Yasutsugu Takada
Journal:  Cancers (Basel)       Date:  2022-01-13       Impact factor: 6.639

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.